• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RADIATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RADIATION Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problems Low Blood Pressure/ Hypotension (1914); Loss of consciousness (2418); Vaso-Vagal Response (2661)
Event Date 11/03/2014
Event Type  Injury  
Event Description
Acute hypotension grade 4 attribution 3.Vasovagal reaction grade 4 attribution 3.Cycle 1.Pt was started on docetaxel, after 2 mins of chemo infusion, pt started having an acute reaction.He was hypotensive (80s/50s) and was passing out.Chemo infusion was discontinued.He was resuscitated with iv fluids at 750 ml/hour and pt was able to slowly recover with waking up and was responsive.An ekg was done and was unremarkable.His vital signs were back to stable range (130s/80s) in around 15 to 20 mins and he was able to go home.Diagnosis for use: right tonsil carcinoma.Dose, frequency, and route used/therapy dates: radiation, bid for 14 days.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RADIATION
Type of Device
RADIATION
MDR Report Key4270293
MDR Text Key5293812
Report NumberMW5039149
Device Sequence Number1
Product Code IYE
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/13/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/13/2014
Patient Sequence Number1
Treatment
DOCETAXEL, 28 MG, DAYS 1 & 8, IV
Patient Outcome(s) Required Intervention;
Patient Weight73
-
-